Diagnostic efficacy of 18F-FAPI-74 PET/CT in patients with colon cancer

Status

Not yet recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-510651-35-00

Enrollment

100

Registered

2024-08-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon cancer

Brief summary

FAPI-74-PET/CT has a 70 % sensitivity in detecting metastathic lymph nodes

Interventions

DRUG[18F]FAPI-74

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
FAPI-74-PET/CT has a 70 % sensitivity in detecting metastathic lymph nodes	—

Countries

Finland

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026